A Study to Evaluate the Effectiveness of Intralesional Vitamin D Injections for Treatment of Common Warts

Overview

About this study

The purpose of this study is to explore the effectiveness of intralesional vitamin D injection into cutaneous warts by comparing the rates of wart improvement and resolution between a population randomly selected to receive either blinded Vitamin D wart injections or placebo.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult Employee and Community Health (ECH) patients seen at the Mayo Clinic Rochester practices.
  • Patients suffering from one or more cutaneous warts as diagnosed by the examining physician at baseline visit on typical diagnostic characteristics.
  • Able to provide consent.
  • Both recalcitrant and non-recalcitrant warts will be included.

Exclusion Criteria:

  • Patients with prior use of home or office-based destructive treatments for this wart(s) in the last 1 month with SA or cryotherapy.
  • Immunoadjuvant therapy for warts in the last 4 months (e.g Candida).
  • History of vitamin D injection of warts ever.
  • High-dose vitamin D supplementation (> 4,000 IU daily or equivalent) in the preceding 3 months.
  • Pregnancy or lactation.
  • Facial or genital warts.
  • Lesions not felt by the examining clinician to be a wart (e.g., corns or calluses).
  • Immunosuppression (to include immunosuppressive medications or conditions as judged by the physician evaluating the patient at the baseline visit).
  • Allergy to sesame oil.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Stephen Merry, M.D.

Closed for enrollment

Contact information:

Stephen Merry M.D.

(507) 284-5180

Merry.Stephen@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20483480

Mayo Clinic Footer